CD8A and neoplasm: Tumor-antagonizing immune cells, such as CD8+ cytotoxic T cells, target and kill tumor cells in the early stages of cancer; tumor-promoting immune cells, such as Myeloid-Derived Suppressor Cells (MDSCs), suppress the immune response in the body and support cancer progression [87].